{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:31:59Z","timestamp":1789450319401,"version":"build-2803163510"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40266-026-01291-z","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:14:22Z","timestamp":1776867262000},"page":"385-395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacological Management of ADHD in Women Across Perimenopause, Menopause and Post-Menopause"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1098-0180","authenticated-orcid":false,"given":"Dora","family":"Wynchank","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8644-6323","authenticated-orcid":false,"given":"Sandra","family":"Kooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"2","key":"1291_CR1","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4088\/JCP.10m06628","volume":"73","author":"A Turgay","year":"2012","unstructured":"Turgay A, Goodman DW, Asherson P, Lasser RA, Babcock TF, Pucci ML, et al. Lifespan persistence of ADHD: the life transition model and its application. J Clin Psychiatry. 2012;73(2):192\u2013201.","journal-title":"J Clin Psychiatry"},{"key":"1291_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-020-02707-9","volume":"20","author":"S Young","year":"2020","unstructured":"Young S, Adamo N, \u00c1sgeirsd\u00f3ttir BB, Branney P, Beckett M, Colley W, et al. Females with ADHD: an expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit\/hyperactivity disorder in girls and women. BMC Psychiatry. 2020;20:1\u201327.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"1291_CR3","volume":"16","author":"PO Quinn","year":"2014","unstructured":"Quinn PO, Madhoo M. A review of attention-deficit\/hyperactivity disorder in women and girls: uncovering this hidden diagnosis. Prim Care Companion CNS Disord. 2014;16(3):PCC.13r01596.","journal-title":"Prim Care Companion CNS Disord"},{"issue":"4","key":"1291_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/jcpp.13480","volume":"63","author":"SP Hinshaw","year":"2022","unstructured":"Hinshaw SP, Nguyen PT, O\u2019Grady SM, Rosenthal EA. Annual research review: attention-deficit\/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directions. J Child Psychol Psychiatry. 2022;63(4):484\u201396.","journal-title":"J Child Psychol Psychiatry"},{"issue":"4","key":"1291_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00787-018-1211-3","volume":"28","author":"FD Mowlem","year":"2019","unstructured":"Mowlem FD, Rosenqvist MA, Martin J, Lichtenstein P, Asherson P, Larsson H. Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment. Eur Child Adolesc Psychiatry. 2019;28(4):481\u20139.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"1","key":"1291_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/1460-6984.12056","volume":"49","author":"BC Green","year":"2014","unstructured":"Green BC, Johnson KA, Bretherton L. Pragmatic language difficulties in children with hyperactivity and attention problems: an integrated review. Int J Lang Commun Disord. 2014;49(1):15\u201329.","journal-title":"Int J Lang Commun Disord"},{"issue":"16","key":"1291_CR7","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1017\/S0033291717001416","volume":"47","author":"AJ Capusan","year":"2017","unstructured":"Capusan AJ, Yao S, Kuja-Halkola R, Bulik CM, Thornton LM, Bendtsen P, et al. Genetic and environmental aspects in the association between attention-deficit hyperactivity disorder symptoms and binge-eating behavior in adults: a twin study. Psychol Med. 2017;47(16):2866\u201378.","journal-title":"Psychol Med"},{"issue":"2","key":"1291_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10802-015-0036-5","volume":"44","author":"JI Meza","year":"2016","unstructured":"Meza JI, Owens EB, Hinshaw SP. Response inhibition, peer preference and victimization, and self-harm: longitudinal associations in young adult women with and without ADHD. J Abnorm Child Psychol. 2016;44(2):323\u201334.","journal-title":"J Abnorm Child Psychol"},{"issue":"1","key":"1291_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12888-020-2442-7","volume":"20","author":"A Beheshti","year":"2020","unstructured":"Beheshti A, Chavanon ML, Christiansen H. Emotion dysregulation in adults with attention deficit hyperactivity disorder: a meta-analysis. BMC Psychiatry. 2020;20(1):120.","journal-title":"BMC Psychiatry"},{"issue":"11","key":"1291_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0277175","volume":"17","author":"WS Choi","year":"2022","unstructured":"Choi WS, Woo YS, Wang SM, Lim HK, Bahk WM. The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: a systematic literature review. PLoS ONE. 2022;17(11):e0277175.","journal-title":"PLoS ONE"},{"key":"1291_CR11","first-page":"137","volume":"5","author":"D McIntosh","year":"2009","unstructured":"McIntosh D, Kutcher S, Binder C, Levitt A, Fallu A, Rosenbluth M. Adult ADHD and comorbid depression: a consensus-derived diagnostic algorithm for ADHD. Neuropsychiatr Dis Treat. 2009;5:137\u201350.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1291_CR12","doi-asserted-by":"publisher","first-page":"1613628","DOI":"10.3389\/fgwh.2025.1613628","volume":"6","author":"JJS Kooij","year":"2025","unstructured":"Kooij JJS, de Jong M, Agnew-Blais J, Amoretti S, Bang Madsen K, Barclay I, et al. Research advances and future directions in female ADHD: the lifelong interplay of hormonal fluctuations with mood, cognition, and disease. Front Glob Womens Health. 2025;6:1613628.","journal-title":"Front Glob Womens Health."},{"issue":"3","key":"1291_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ogc.2011.05.006","volume":"38","author":"RC Thurston","year":"2011","unstructured":"Thurston RC, Joffe H. Vasomotor symptoms and menopause: findings from the Study of Women\u2019s Health across the Nation. Obstet Gynecol Clin North Am. 2011;38(3):489\u2013501.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"4","key":"1291_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11914-009-0021-4","volume":"7","author":"M Zaidi","year":"2009","unstructured":"Zaidi M, Turner CH, Canalis E, Pacifici R, Sun L, Iqbal J, et al. Bone loss or lost bone: rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss. Curr Osteoporos Rep. 2009;7(4):118\u201326.","journal-title":"Curr Osteoporos Rep"},{"issue":"5\u20136","key":"1291_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000073591","volume":"32","author":"R Rossi","year":"2002","unstructured":"Rossi R, Grimaldi T, Origliani G, Fantini G, Coppi F, Modena MG. Menopause and cardiovascular risk. Pathophysiol Haemost Thromb. 2002;32(5\u20136):325\u20138.","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"7","key":"1291_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1001\/jamacardio.2016.2415","volume":"1","author":"T Muka","year":"2016","unstructured":"Muka T, Oliver-Williams C, Kunutsor S, Laven JS, Fauser BC, Chowdhury R, et al. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis. JAMA Cardiol. 2016;1(7):767\u201376.","journal-title":"JAMA Cardiol."},{"issue":"2","key":"1291_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3109\/13697137.2012.753873","volume":"16","author":"F Guidozzi","year":"2013","unstructured":"Guidozzi F. Sleep and sleep disorders in menopausal women. Climacteric. 2013;16(2):214\u20139.","journal-title":"Climacteric"},{"key":"1291_CR18","doi-asserted-by":"publisher","first-page":"8842110","DOI":"10.1155\/2020\/8842110","volume":"2020","author":"CB Lu","year":"2020","unstructured":"Lu CB, Liu PF, Zhou YS, Meng FC, Qiao TY, Yang XJ, et al. Musculoskeletal Pa Musculoskeletal pain during the menopausal transition: a systematic review and meta-analysis. Neural Plast. 2020;2020:8842110.","journal-title":"Neural Plast"},{"key":"1291_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.848202","volume":"9","author":"NH Nik Hazlina","year":"2022","unstructured":"Nik Hazlina NH, Norhayati MN, Shaiful Bahari I, Nik Muhammad Arif NA. Prevalence of psychosomatic and genitourinary syndrome among menopausal women: a systematic review and meta-analysis. Front Med (Lausanne). 2022;9:848202.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"1291_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/GRF.0000000000000389","volume":"61","author":"L Delamater","year":"2018","unstructured":"Delamater L, Santoro N. Management of the perimenopause. Clin Obstet Gynecol. 2018;61(3):419\u201332.","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"1291_CR21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0193945909354343","volume":"32","author":"EO Im","year":"2010","unstructured":"Im EO, Lee B, Chee W, Brown A, Dormire S. Menopausal symptoms among four major ethnic groups in the United States. West J Nurs Res. 2010;32(4):540\u201365.","journal-title":"West J Nurs Res"},{"key":"1291_CR22","doi-asserted-by":"publisher","first-page":"1496889","DOI":"10.3389\/fpsyt.2025.1496889","volume":"16","author":"L Gao","year":"2025","unstructured":"Gao L, Wang J, Zhang Y, Zhao X, Fu H. Psychological and cultural correlates of illness conception and menopausal symptoms: a cross-sectional and longitudinal comparative study of Mosuo, Yi, and Han women. Front Psychiatry. 2025;16:1496889.","journal-title":"Front Psychiatry."},{"issue":"6","key":"1291_CR23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/GME.0000000000002349","volume":"31","author":"A Kochersberger","year":"2024","unstructured":"Kochersberger A, Coakley A, Millheiser L, Morris JR, Manneh C, Jackson A, et al. The association of race, ethnicity, and socioeconomic status on the severity of menopause symptoms: a study of 68,864 women. Menopause. 2024;31(6):476\u201383.","journal-title":"Menopause"},{"issue":"1","key":"1291_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/08964289.2021.1958739","volume":"49","author":"J Dotlic","year":"2023","unstructured":"Dotlic J, Markovic N, Gazibara T. Patterns of smoking and menopause-specific quality of life: smoking duration matters more. Behav Med. 2023;49(1):29\u201339.","journal-title":"Behav Med"},{"issue":"1","key":"1291_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12905-025-03662-x","volume":"25","author":"GT Namara","year":"2025","unstructured":"Namara GT, Woldeyes BS, Irenso DY, Fekene DB, Bulto GA, Fata MA, et al. Severe menopausal symptoms and associated factors among post-menopausal women in Ambo town, West Shewa, Ethiopia: a cross-sectional study. BMC Womens Health. 2025;25(1):130.","journal-title":"BMC Womens Health"},{"issue":"7","key":"1291_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14247","volume":"75","author":"S Yilmaz","year":"2021","unstructured":"Yilmaz S, Arslan I, Yengil Taci D. The effect of physical activity and depressive mood on menopausal symptoms in postmenopausal women. Int J Clin Pract. 2021;75(7):e14247.","journal-title":"Int J Clin Pract"},{"issue":"1","key":"1291_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s40572-022-00334-y","volume":"9","author":"AM Neff","year":"2022","unstructured":"Neff AM, Laws MJ, Warner GR, Flaws JA. The effects of environmental contaminant exposure on reproductive aging and the menopause transition. Curr Environ Health Rep. 2022;9(1):53\u201379.","journal-title":"Curr Environ Health Rep"},{"issue":"10","key":"1291_CR28","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/GME.0000000000001130","volume":"25","author":"LE Waetjen","year":"2018","unstructured":"Waetjen LE, Crawford SL, Chang PY, Reed BD, Hess R, Avis NE, et al. Factors associated with developing vaginal dryness symptoms in women transitioning through menopause: a longitudinal study. Menopause. 2018;25(10):1094\u2013104.","journal-title":"Menopause"},{"issue":"9","key":"1291_CR29","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/GME.0000000000000196","volume":"21","author":"EW Freeman","year":"2014","unstructured":"Freeman EW, Sammel MD, Sanders RJ. Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause. 2014;21(9):924\u201332.","journal-title":"Menopause"},{"issue":"1","key":"1291_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41588-018-0269-7","volume":"51","author":"D Demontis","year":"2019","unstructured":"Demontis D, Walters RK, Martin J, Mattheisen M, Als TD, Agerbo E, et al. Discovery of the first genome-wide significant risk loci for attention deficit\/hyperactivity disorder. Nat Genet. 2019;51(1):63\u201375.","journal-title":"Nat Genet"},{"issue":"1","key":"1291_CR31","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12905-022-02021-4","volume":"22","author":"D Peycheva","year":"2022","unstructured":"Peycheva D, Sullivan A, Hardy R, Bryson A, Conti G, Ploubidis G. Risk factors for natural menopause before the age of 45: evidence from two British population-based birth cohort studies. BMC Womens Health. 2022;22(1):438.","journal-title":"BMC Womens Health"},{"issue":"12","key":"1291_CR32","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.108.776823","volume":"118","author":"RC Thurston","year":"2008","unstructured":"Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women\u2019s Health Across the Nation Heart Study. Circulation. 2008;118(12):1234\u201340.","journal-title":"Circulation"},{"issue":"2","key":"1291_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/gme.0b013e3181857964","volume":"16","author":"CJ Crandall","year":"2009","unstructured":"Crandall CJ, Zheng Y, Crawford SL, Thurston RC, Gold EB, Johnston JM, et al. Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis. Menopause. 2009;16(2):239\u201346.","journal-title":"Menopause"},{"issue":"4","key":"1291_CR34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/13697137.2015.1020484","volume":"18","author":"SS Faubion","year":"2015","unstructured":"Faubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 2015;18(4):483\u201391.","journal-title":"Climacteric"},{"issue":"7","key":"1291_CR35","doi-asserted-by":"publisher","first-page":"6566","DOI":"10.3390\/ijms24076566","volume":"24","author":"M Sochocka","year":"2023","unstructured":"Sochocka M, Karska J, Pszczolowska M, Ochnik M, Fulek M, Fulek K, et al. Cognitive decline in early and premature menopause. Int J Mol Sci. 2023;24(7):6566.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1291_CR36","doi-asserted-by":"publisher","first-page":"530","DOI":"10.14283\/jpad.2023.28","volume":"10","author":"H Ding","year":"2023","unstructured":"Ding H, Li Y, Ang TFA, Liu Y, Devine S, Au R, et al. Reproductive markers in Alzheimer\u2019s disease progression: the Framingham Heart Study. J Prev Alzheimers Dis. 2023;10(3):530\u20135.","journal-title":"J Prev Alzheimers Dis"},{"issue":"4","key":"1291_CR37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jagp.2023.10.018","volume":"32","author":"BL Callahan","year":"2024","unstructured":"Callahan BL, Becker S, Ramirez J, Taylor R, Shammi P, Gao F, et al. Vascular burden moderates the relationship between ADHD and cognition in older adults. Am J Geriatr Psychiatry. 2024;32(4):427\u201342. https:\/\/doi.org\/10.1016\/j.jagp.2023.10.018.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"10","key":"1291_CR38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s11920-023-01447-3","volume":"25","author":"CA Metcalf","year":"2023","unstructured":"Metcalf CA, Duffy KA, Page CE, Novick AM. Cognitive problems in perimenopause: a review of recent evidence. Curr Psychiatry Rep. 2023;25(10):501\u201311.","journal-title":"Curr Psychiatry Rep"},{"issue":"14","key":"1291_CR39","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1177\/10870547251355006","volume":"29","author":"L Chapman","year":"2025","unstructured":"Chapman L, Gupta K, Hunter MS, Dommett EJ. Examining the link between ADHD symptoms and menopausal experiences. J Atten Disord. 2025;29(14):1263\u201377.","journal-title":"J Atten Disord"},{"issue":"6","key":"1291_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.biopsych.2019.04.028","volume":"86","author":"GE Hodes","year":"2019","unstructured":"Hodes GE, Epperson CN. Sex differences in vulnerability and resilience to stress across the life span. Biol Psychiatry. 2019;86(6):421\u201332.","journal-title":"Biol Psychiatry"},{"issue":"14","key":"1291_CR41","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1177\/10497323241253412","volume":"34","author":"E Craddock","year":"2024","unstructured":"Craddock E. Being a woman is 100% significant to my experiences of Attention Deficit Hyperactivity Disorder and Autism: exploring the gendered implications of an adulthood combined Autism and Attention Deficit Hyperactivity Disorder diagnosis. Qual Health Res. 2024;34(14):1442\u201355.","journal-title":"Qual Health Res"},{"issue":"10","key":"1291_CR42","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jama.2009.1308","volume":"302","author":"ND Volkow","year":"2009","unstructured":"Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F, et al. Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA. 2009;302(10):1084\u201391.","journal-title":"JAMA"},{"key":"1291_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1492126","volume":"15","author":"HJ MacDonald","year":"2024","unstructured":"MacDonald HJ, Kleppe R, Szigetvari PD, Haavik J. The dopamine hypothesis for ADHD: an evaluation of evidence accumulated from human studies and animal models. Front Psychiatry. 2024;15:1492126.","journal-title":"Front Psychiatry"},{"issue":"3","key":"1291_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2174\/1566524023666230522145950","volume":"25","author":"S Shafiullah","year":"2025","unstructured":"Shafiullah S, Dhaneshwar S. Current perspectives on attention-deficit hyperactivity disorder. Curr Mol Med. 2025;25(3):289\u2013304.","journal-title":"Curr Mol Med"},{"issue":"9","key":"1291_CR45","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1177\/10870547251332319","volume":"29","author":"E Osianlis","year":"2025","unstructured":"Osianlis E, Thomas EHX, Jenkins LM, Gurvich C. ADHD and sex hormones in females: a systematic review. J Atten Disord. 2025;29(9):706\u201323.","journal-title":"J Atten Disord"},{"key":"1291_CR46","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.yhbeh.2015.06.001","volume":"74","author":"EK Diekhof","year":"2015","unstructured":"Diekhof EK. Be quick about it. Endogenous estradiol level, menstrual cycle phase and trait impulsiveness predict impulsive choice in the context of reward acquisition. Horm Behav. 2015;74:186\u201393.","journal-title":"Horm Behav"},{"issue":"1","key":"1291_CR47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1124\/jpet.116.237412","volume":"360","author":"A Crider","year":"2017","unstructured":"Crider A, Pillai A. Estrogen signaling as a therapeutic target in neurodevelopmental disorders. J Pharmacol Exp Ther. 2017;360(1):48\u201358.","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"1291_CR48","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/0006-3223(94)00181-2","volume":"37","author":"U Halbreich","year":"1995","unstructured":"Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry. 1995;37(7):434\u201341.","journal-title":"Biol Psychiatry"},{"issue":"13","key":"1291_CR49","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2165\/11635960-000000000-00000","volume":"72","author":"J Ryan","year":"2012","unstructured":"Ryan J, Ancelin ML. Polymorphisms of estrogen receptors and risk of depression: therapeutic implications. Drugs. 2012;72(13):1725\u201338.","journal-title":"Drugs"},{"issue":"Suppl. 1","key":"1291_CR50","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.33588\/rn.58S01.2013570","volume":"58","author":"K Rubia","year":"2014","unstructured":"Rubia K, Alegria AA, Brinson H. Brain abnormalities in attention-deficit hyperactivity disorder: a review. Rev Neurol. 2014;58(Suppl. 1):S3-16.","journal-title":"Rev Neurol"},{"issue":"8","key":"1291_CR51","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1177\/10870547251315601","volume":"29","author":"IL Rapoport","year":"2025","unstructured":"Rapoport IL, Groenman AP. A review of sex and gender factors in stimulant treatment for ADHD: knowledge gaps and future directions. J Atten Disord. 2025;29(8):602\u201316.","journal-title":"J Atten Disord"},{"issue":"3","key":"1291_CR52","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.yfrne.2014.03.003","volume":"35","author":"W Davies","year":"2014","unstructured":"Davies W. Sex differences in attention deficit hyperactivity disorder: candidate genetic and endocrine mechanisms. Front Neuroendocrinol. 2014;35(3):331\u201346.","journal-title":"Front Neuroendocrinol"},{"key":"1291_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1306194","volume":"14","author":"M de Jong","year":"2023","unstructured":"de Jong M, Wynchank D, van Andel E, Beekman ATF, Kooij JJS. Female-specific pharmacotherapy in ADHD: premenstrual adjustment of psychostimulant dosage. Front Psychiatry. 2023;14:1306194.","journal-title":"Front Psychiatry"},{"key":"1291_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.srhc.2024.100975","volume":"40","author":"I Burger","year":"2024","unstructured":"Burger I, Erlandsson K, Borneskog C. Perceived associations between the menstrual cycle and attention deficit hyperactivity disorder (ADHD): a qualitative interview study exploring lived experiences. Sex Reprod Healthc. 2024;40:100975.","journal-title":"Sex Reprod Healthc"},{"key":"1291_CR55","unstructured":"Rodgers AL. We demand attention! A call for greater research on women with ADHD: ADDitude 2024. https:\/\/www.additudemag.com\/health-equity-adhd-in-women-research\/. Accessed 9 Mar 2026."},{"issue":"1","key":"1291_CR56","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2025.10101","volume":"68","author":"U Jakobsdottir Smari","year":"2025","unstructured":"Jakobsdottir Smari U, Valdimarsdottir UA, Wynchank D, de Jong M, Aspelund T, Hauksdottir A, et al. Perimenopausal symptoms in women with and without ADHD: a population-based cohort study. Eur Psychiatry. 2025;68(1):e133.","journal-title":"Eur Psychiatry"},{"key":"1291_CR57","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jpsychires.2020.12.005","volume":"133","author":"F Dorani","year":"2021","unstructured":"Dorani F, Bijlenga D, Beekman ATF, van Someren EJW, Kooij JJS. Prevalence of hormone-related mood disorder symptoms in women with ADHD. J Psychiatr Res. 2021;133:10\u20135.","journal-title":"J Psychiatr Res"},{"key":"1291_CR58","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-642-30726-3_5","volume":"214","author":"I Spoletini","year":"2012","unstructured":"Spoletini I, Vitale C, Malorni W, Rosano GM. Sex differences in drug effects: interaction with sex hormones in adult life. Handb Exp Pharmacol. 2012;214:91\u2013105.","journal-title":"Handb Exp Pharmacol"},{"issue":"6","key":"1291_CR59","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1080\/17425255.2025.2481891","volume":"21","author":"EL Bosch","year":"2025","unstructured":"Bosch EL, Sommer IEC, Touw DJ. The influence of female sex and estrogens on drug pharmacokinetics: what is the evidence? Expert Opin Drug Metab Toxicol. 2025;21(6):637\u201347.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"1291_CR60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/oby.23289","volume":"30","author":"KL Marlatt","year":"2022","unstructured":"Marlatt KL, Pitynski-Miller DR, Gavin KM, Moreau KL, Melanson EL, Santoro N, et al. Body composition and cardiometabolic health across the menopause transition. Obesity (Silver Spring). 2022;30(1):14\u201327.","journal-title":"Obesity (Silver Spring)"},{"issue":"10","key":"1291_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12101342","volume":"12","author":"A Gonzalez-Rodriguez","year":"2022","unstructured":"Gonzalez-Rodriguez A, Monreal JA, Seeman MV. The effect of menopause on antipsychotic response. Brain Sci. 2022;12(10):1342.","journal-title":"Brain Sci"},{"issue":"2","key":"1291_CR62","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5455\/msm.2021.33.114-118","volume":"33","author":"E Antoniou","year":"2021","unstructured":"Antoniou E, Rigas N, Orovou E, Papatrechas A, Sarella A. ADHD symptoms in females of childhood, adolescent, reproductive and menopause period. Mater Sociomed. 2021;33(2):114\u20138.","journal-title":"Mater Sociomed"},{"key":"1291_CR63","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.maturitas.2023.01.007","volume":"170","author":"CE Page","year":"2023","unstructured":"Page CE, Soreth B, Metcalf CA, Johnson RL, Duffy KA, Sammel MD, et al. Natural vs. surgical postmenopause and psychological symptoms confound the effect of menopause on executive functioning domains of cognitive experience. Maturitas. 2023;170:64\u201373.","journal-title":"Maturitas"},{"key":"1291_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00037","volume":"9","author":"C Barth","year":"2015","unstructured":"Barth C, Villringer A, Sacher J. Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Front Neurosci. 2015;9:37.","journal-title":"Front Neurosci"},{"issue":"5","key":"1291_CR65","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3109\/13697137.2016.1152536","volume":"19","author":"A Pines","year":"2016","unstructured":"Pines A. Midlife ADHD in women: any relevance to menopause? Climacteric. 2016;19(5):423\u20135.","journal-title":"Climacteric"},{"issue":"6","key":"1291_CR66","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/1087054716676342","volume":"22","author":"K Yoshimasu","year":"2018","unstructured":"Yoshimasu K, Barbaresi WJ, Colligan RC, Voigt RG, Killian JM, Weaver AL, et al. Adults with persistent ADHD: gender and psychiatric comorbidities: a population-based longitudinal study. J Atten Disord. 2018;22(6):535\u201346.","journal-title":"J Atten Disord"},{"issue":"16","key":"1291_CR67","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1007\/s00213-015-3953-7","volume":"232","author":"CN Epperson","year":"2015","unstructured":"Epperson CN, Shanmugan S, Kim DR, Mathews S, Czarkowski KA, Bradley J, et al. New onset executive function difficulties at menopause: a possible role for lisdexamfetamine. Psychopharmacology. 2015;232(16):3091\u2013100.","journal-title":"Psychopharmacology"},{"key":"1291_CR68","doi-asserted-by":"publisher","unstructured":"Wynchank D, de Jong M, Kooij SJJS. Practical tools for female-specifi c ADHD: The impact of hormonal fl uctuations in clinical practice and from the literature. Eur Psychiatry. 2025;69(1):e1. https:\/\/doi.org\/10.1192\/j.eurpsy.2025.10120.","DOI":"10.1192\/j.eurpsy.2025.10120"},{"key":"1291_CR69","unstructured":"NICE. Attention deficit hyperactivity disorder: diagnosis and management (NICE Guideline No. NG87). 2018. https:\/\/www.nice.org.uk\/guidance\/ng87. Accessed 9 Mar 2026."},{"issue":"2","key":"1291_CR70","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/npp.2016.162","volume":"42","author":"S Shanmugan","year":"2017","unstructured":"Shanmugan S, Loughead J, Nanga RP, Elliott M, Hariharan H, Appleby D, et al. Lisdexamfetamine effects on executive activation and neurochemistry in menopausal women with executive function difficulties. Neuropsychopharmacology. 2017;42(2):437\u201345.","journal-title":"Neuropsychopharmacology"},{"key":"1291_CR71","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ygyno.2024.07.689","volume":"190","author":"CA Metcalf","year":"2024","unstructured":"Metcalf CA, Page CE, Stocker BOS, Johnson RL, Duffy KA, Sammel MD, et al. Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: a randomized controlled crossover trial of lisdexamfetamine. Gynecol Oncol. 2024;190:62\u20139.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1291_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02707-9","volume":"20","author":"S Young","year":"2020","unstructured":"Young S, Adamo N, Asgeirsdottir BB, Branney P, Beckett M, Colley W, et al. Females with ADHD: an expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit\/ hyperactivity disorder in girls and women. BMC Psychiatry. 2020;20(1):404.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"1291_CR73","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4088\/JCP.v66n0215","volume":"66","author":"TE Wilens","year":"2005","unstructured":"Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, et al. Blood pressure changes associated with medication treatment of adults with attention-deficit\/hyperactivity disorder. J Clin Psychiatry. 2005;66(2):253\u20139.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1291_CR74","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1001\/jamapsychiatry.2023.4294","volume":"81","author":"L Zhang","year":"2024","unstructured":"Zhang L, Li L, Andell P, Garcia-Argibay M, Quinn PD, D\u2019Onofrio BM, et al. Attention-deficit\/hyperactivity disorder medications and long-term risk of cardiovascular diseases. JAMA Psychiat. 2024;81(2):178\u201387.","journal-title":"JAMA Psychiat"},{"issue":"1","key":"1291_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03178-2","volume":"14","author":"E Du Rietz","year":"2024","unstructured":"Du Rietz E, Xie T, Wang R, Cheesman R, Garcia-Argibay M, Dong Z, et al. The contribution of attention-deficit\/hyperactivity disorder polygenic load to metabolic and cardiovascular health outcomes: a large-scale population and sibling study. Transl Psychiatry. 2024;14(1):470.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"1291_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03174-1","volume":"21","author":"M Dobrosavljevic","year":"2023","unstructured":"Dobrosavljevic M, Kuja-Halkola R, Li L, Chang Z, Larsson H, Du Rietz E. Attention-deficit\/hyperactivity disorder symptoms and subsequent cardiometabolic disorders in adults: investigating underlying mechanisms using a longitudinal twin study. BMC Med. 2023;21(1):452.","journal-title":"BMC Med"},{"issue":"3","key":"1291_CR77","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/wps.21020","volume":"21","author":"L Li","year":"2022","unstructured":"Li L, Chang Z, Sun J, Garcia-Argibay M, Du Rietz E, Dobrosavljevic M, et al. Attention-deficit\/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study. World Psychiatry. 2022;21(3):452\u20139.","journal-title":"World Psychiatry"},{"issue":"11","key":"1291_CR78","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.43597","volume":"5","author":"L Zhang","year":"2022","unstructured":"Zhang L, Yao H, Li L, Du Rietz E, Andell P, Garcia-Argibay M, et al. Risk of cardiovascular diseases associated with medications used in attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(11):e2243597.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"1291_CR79","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S2215-0366(25)00062-8","volume":"12","author":"LC Farhat","year":"2025","unstructured":"Farhat LC, Lannes A, Del Giovane C, Parlatini V, Garcia-Argibay M, Ostinelli EG, et al. Comparative cardiovascular safety of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2025;12(5):355\u201365.","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"1291_CR80","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12916-023-03160-7","volume":"21","author":"UJ Smari","year":"2023","unstructured":"Smari UJ, Valdimarsdottir UA, Aspelund T, Hauksdottir A, Thordardottir EB, Hartman CA, et al. Psychiatric comorbidities in women with cardiometabolic conditions with and without ADHD: a population-based study. BMC Med. 2023;21(1):450.","journal-title":"BMC Med"},{"issue":"6","key":"1291_CR81","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00737-023-01356-7","volume":"26","author":"LS Ter Beek","year":"2023","unstructured":"Ter Beek LS, Bohmer MN, Wittekoek ME, Kooij JJS. Lifetime ADHD symptoms highly prevalent in women with cardiovascular complaints: a cross-sectional study. Arch Womens Ment Health. 2023;26(6):851\u20135.","journal-title":"Arch Womens Ment Health"},{"issue":"5","key":"1291_CR82","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/gme.0b013e3181fcafd6","volume":"18","author":"CN Epperson","year":"2011","unstructured":"Epperson CN, Pittman B, Czarkowski KA, Bradley J, Quinlan DM, Brown TE. Impact of atomoxetine on subjective attention and memory difficulties in perimenopausal and postmenopausal women. Menopause. 2011;18(5):542\u20138.","journal-title":"Menopause"},{"issue":"15","key":"1291_CR83","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1080\/14656566.2019.1645122","volume":"20","author":"RP Garay","year":"2019","unstructured":"Garay RP, Charpeaud T, Logan S, Hannaert P, Garay RG, Llorca PM, et al. Pharmacotherapeutic approaches to treating depression during the perimenopause. Expert Opin Pharmacother. 2019;20(15):1837\u201345.","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"1291_CR84","first-page":"272","volume":"110","author":"C Stubbs","year":"2017","unstructured":"Stubbs C, Mattingly L, Crawford SA, Wickersham EA, Brockhaus JL, McCarthy LH. Do SSRIs and SNRIs reduce the frequency and\/or severity of hot flashes in menopausal women. J Okla State Med Assoc. 2017;110(5):272\u20134.","journal-title":"J Okla State Med Assoc"},{"issue":"1","key":"1291_CR85","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/2327-6924.12137","volume":"27","author":"AP Handley","year":"2015","unstructured":"Handley AP, Williams M. The efficacy and tolerability of SSRI\/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review. J Am Assoc Nurse Pract. 2015;27(1):54\u201361.","journal-title":"J Am Assoc Nurse Pract"},{"issue":"4","key":"1291_CR86","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/13697137.2017.1291607","volume":"20","author":"M L'Hermite","year":"2017","unstructured":"L\u2019Hermite M. Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol progesterone) are optimal. Climacteric. 2017;20(4):331\u20138.","journal-title":"Climacteric"},{"issue":"4","key":"1291_CR87","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0537","volume":"11","author":"P Anagnostis","year":"2022","unstructured":"Anagnostis P, Lambrinoudaki I, Stevenson JC, Goulis DG. Menopause-associated risk of cardiovascular disease. Endocr Connect. 2022;11(4):e210537.","journal-title":"Endocr Connect"},{"issue":"1","key":"1291_CR88","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3810\/pgm.2009.01.1949","volume":"121","author":"K Holtorf","year":"2009","unstructured":"Holtorf K. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy? Postgrad Med. 2009;121(1):73\u201385.","journal-title":"Postgrad Med"},{"issue":"8","key":"1291_CR89","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/GME.0000000000001553","volume":"27","author":"JE Manson","year":"2020","unstructured":"Manson JE, Bassuk SS, Kaunitz AM, Pinkerton JV. The Women\u2019s Health Initiative trials of menopausal hormone therapy: lessons learned. Menopause. 2020;27(8):918\u201328.","journal-title":"Menopause"},{"issue":"7","key":"1291_CR90","doi-asserted-by":"publisher","first-page":"869","DOI":"10.4158\/EP171828.PS","volume":"23","author":"RH Cobin","year":"2017","unstructured":"Cobin RH, Goodman NF, Committee ARES. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on Menopause-2017 update. Endocr Pract. 2017;23(7):869\u201380.","journal-title":"Endocr Pract"},{"issue":"2","key":"1291_CR91","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/clc.22891","volume":"41","author":"RC Chester","year":"2018","unstructured":"Chester RC, Kling JM, Manson JE. What the Women\u2019s Health Initiative has taught us about menopausal hormone therapy. Clin Cardiol. 2018;41(2):247\u201352.","journal-title":"Clin Cardiol"},{"key":"1291_CR92","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/IJWH.S38342","volume":"6","author":"R Sood","year":"2014","unstructured":"Sood R, Faubion SS, Kuhle CL, Thielen JM, Shuster LT. Prescribing menopausal hormone therapy: an evidence-based approach. Int J Womens Health. 2014;6:47\u201357.","journal-title":"Int J Womens Health"},{"issue":"11","key":"1291_CR93","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1210\/jc.2015-2236","volume":"100","author":"CA Stuenkel","year":"2015","unstructured":"Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, et al. Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(11):3975\u20134011.","journal-title":"J Clin Endocrinol Metab"},{"key":"1291_CR94","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.maturitas.2022.10.012","volume":"168","author":"B Stefanowski","year":"2023","unstructured":"Stefanowski B, Kucharski M, Szeliga A, Snopek M, Kostrzak A, Smolarczyk R, et al. Cognitive decline and dementia in women after menopause: prevention strategies. Maturitas. 2023;168:53\u201361.","journal-title":"Maturitas"},{"issue":"4","key":"1291_CR95","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.yhbeh.2014.08.011","volume":"66","author":"VN Luine","year":"2014","unstructured":"Luine VN. Estradiol and cognitive function: past, present and future. Horm Behav. 2014;66(4):602\u201318.","journal-title":"Horm Behav"},{"key":"1291_CR96","doi-asserted-by":"publisher","first-page":"1350318","DOI":"10.3389\/fendo.2024.1350318","volume":"15","author":"C Andy","year":"2024","unstructured":"Andy C, Nerattini M, Jett S, Carlton C, Zarate C, Boneu C, et al. Systematic review and meta-analysis of the effects of menopause hormone therapy on cognition. Front Endocrinol (Lausanne). 2024;15:1350318.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"5","key":"1291_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14051479","volume":"14","author":"L Troia","year":"2025","unstructured":"Troia L, Garassino M, Volpicelli AI, Fornara A, Libretti A, Surico D, et al. Sleep disturbance and perimenopause: a narrative review. J Clin Med. 2025;14(5):1479.","journal-title":"J Clin Med"},{"issue":"5","key":"1291_CR98","first-page":"212","volume":"4","author":"S Jehan","year":"2015","unstructured":"Jehan S, Masters-Isarilov A, Salifu I, Zizi F, Jean-Louis G, Pandi-Perumal SR, et al. Sleep disorders in postmenopausal women. J Sleep Disord Ther. 2015;4(5):212.","journal-title":"J Sleep Disord Ther."},{"issue":"4","key":"1291_CR99","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/13697137.2018.1472567","volume":"21","author":"JC Prior","year":"2018","unstructured":"Prior JC. Progesterone for treatment of symptomatic menopausal women. Climacteric. 2018;21(4):358\u201365.","journal-title":"Climacteric"},{"issue":"12","key":"1291_CR100","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1080\/09513590.2017.1333094","volume":"33","author":"E Leeangkoonsathian","year":"2017","unstructured":"Leeangkoonsathian E, Pantasri T, Chaovisitseree S, Morakot N. The effect of different progestogens on sleep in postmenopausal women: a randomized trial. Gynecol Endocrinol. 2017;33(12):933\u20136.","journal-title":"Gynecol Endocrinol"},{"issue":"5 Suppl. 7","key":"1291_CR101","first-page":"S16","volume":"48","author":"U Halbreich","year":"1997","unstructured":"Halbreich U. Role of estrogen in postmenopausal depression. Neurology. 1997;48(5 Suppl. 7):S16\u20139.","journal-title":"Neurology"},{"issue":"5","key":"1291_CR102","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/GME.0000000000000323","volume":"22","author":"E Toffol","year":"2015","unstructured":"Toffol E, Heikinheimo O, Partonen T. Hormone therapy and mood in perimenopausal and postmenopausal women: a narrative review. Menopause. 2015;22(5):564\u201378.","journal-title":"Menopause"},{"issue":"2","key":"1291_CR103","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/bmjsrh-2023-202099","volume":"50","author":"C Hemachandra","year":"2024","unstructured":"Hemachandra C, Taylor S, Islam RM, Fooladi E, Davis SR. A systematic review and critical appraisal of menopause guidelines. BMJ Sex Reprod Health. 2024;50(2):122\u201338.","journal-title":"BMJ Sex Reprod Health"},{"issue":"3","key":"1291_CR104","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/PPO.0000000000000591","volume":"28","author":"HN Hodis","year":"2022","unstructured":"Hodis HN, Mack WJ. Menopausal hormone replacement therapy and reduction of all-cause mortality and cardiovascular disease: it is about time and timing. Cancer J. 2022;28(3):208\u201323.","journal-title":"Cancer J"},{"issue":"16","key":"1291_CR105","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1056\/NEJM199310143291601","volume":"329","author":"DT Felson","year":"1993","unstructured":"Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med. 1993;329(16):1141\u20136.","journal-title":"N Engl J Med"},{"key":"1291_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2025.1542746","volume":"7","author":"O Platt","year":"2025","unstructured":"Platt O, Bateman J, Bakour S. Impact of menopause hormone therapy, exercise, and their combination on bone mineral density and mental wellbeing in menopausal women: a scoping review. Front Reprod Health. 2025;7:1542746.","journal-title":"Front Reprod Health"},{"issue":"11","key":"1291_CR107","first-page":"884","volume":"94","author":"DA Hill","year":"2016","unstructured":"Hill DA, Crider M, Hill SR. Hormone therapy and other treatments for symptoms of menopause. Am Fam Physician. 2016;94(11):884\u20139.","journal-title":"Am Fam Physician"},{"issue":"8","key":"1291_CR108","volume":"2016","author":"A Lethaby","year":"2016","unstructured":"Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;2016(8):CD001500.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1291_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101815","volume":"38","author":"P Stute","year":"2024","unstructured":"Stute P, Walker LJ, Eicher A, Pavicic E, Kolokythas A, Theis S, et al. Progestogens for endometrial protection in combined menopausal hormone therapy: a systematic review. Best Pract Res Clin Endocrinol Metab. 2024;38(1):101815.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10","key":"1291_CR110","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-082749","volume":"14","author":"C Lundell","year":"2024","unstructured":"Lundell C, Stergiopoulos N, Blomberg L, Ujvari D, Schuppe-Koistinen I, Kopp-Kallner H, et al. Breast and endometrial safety of micronised progesterone versus norethisterone acetate in menopausal hormone therapy (PROBES): study protocol of a double-blind randomised controlled trial. BMJ Open. 2024;14(10):e082749.","journal-title":"BMJ Open"},{"issue":"2","key":"1291_CR111","first-page":"131","volume":"24","author":"M Binkowska","year":"2025","unstructured":"Binkowska M, Paszkowski T, Skrzypulec-Plinta V, Zgliczynski W. Position paper of the expert panel of the Polish Society of Menopause and Andropause on the use of Oestrogel\u00ae in menopausal hormone therapy. Prz Menopauzalny. 2025;24(2):131\u20136.","journal-title":"Prz Menopauzalny"},{"issue":"4","key":"1291_CR112","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/GME.0000000000001221","volume":"26","author":"C Biehl","year":"2019","unstructured":"Biehl C, Plotsker O, Mirkin S. A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause. Menopause. 2019;26(4):431\u201353.","journal-title":"Menopause"},{"issue":"4","key":"1291_CR113","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/13697137.2023.2218998","volume":"26","author":"RE Nappi","year":"2023","unstructured":"Nappi RE, Tiranini L, Martini E, Bosoni D, Cassani C, Cucinella L. Different local estrogen therapies for a tailored approach to GSM. Climacteric. 2023;26(4):361\u20136.","journal-title":"Climacteric"},{"issue":"3","key":"1291_CR114","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/AOG.0000000000001349","volume":"127","author":"ACOG Committee","year":"2016","unstructured":"ACOG Committee. Opinion No. 659 summary: the use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Obstet Gynecol. 2016;127(3):618\u20139.","journal-title":"Obstet Gynecol"},{"key":"1291_CR115","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.eurpsy.2018.11.001","volume":"56","author":"JJS Kooij","year":"2019","unstructured":"Kooij JJS, Bijlenga D, Salerno L, Jaeschke R, Bitter I, Balazs J, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2019;56:14\u201334.","journal-title":"Eur Psychiatry"},{"issue":"2","key":"1291_CR116","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1034\/j.1600-079X.2001.280207.x","volume":"28","author":"Y Okatani","year":"2000","unstructured":"Okatani Y, Morioka N, Wakatsuki A. Changes in nocturnal melatonin secretion in perimenopausal women: correlation with endogenous estrogen concentrations. J Pineal Res. 2000;28(2):111\u20138.","journal-title":"J Pineal Res"},{"issue":"5","key":"1291_CR117","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/GME.0b013e3182a6c8f3","volume":"21","author":"E Toffol","year":"2014","unstructured":"Toffol E, Kalleinen N, Haukka J, Vakkuri O, Partonen T, Polo-Kantola P. Melatonin in perimenopausal and postmenopausal women: associations with mood, sleep, climacteric symptoms, and quality of life. Menopause. 2014;21(5):493\u2013500.","journal-title":"Menopause"},{"key":"1291_CR118","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1196\/annals.1356.030","volume":"1057","author":"G Bellipanni","year":"2005","unstructured":"Bellipanni G, F DIM, Blasi F, Di Marzo A. Effects of melatonin in perimenopausal and menopausal women: our personal experience. Ann N Y Acad Sci. 2005;1057:393\u2013402.","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"1291_CR119","first-page":"1405","volume":"43","author":"N Parandavar","year":"2014","unstructured":"Parandavar N, Abdali K, Keshtgar S, Emamghoreishi M, Amooee S. The effect of melatonin on climacteric symptoms in menopausal women: a double-blind, randomized controlled, clinical trial. Iran J Public Health. 2014;43(10):1405\u201316.","journal-title":"Iran J Public Health"},{"key":"1291_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2017.00228","volume":"8","author":"D Anand","year":"2017","unstructured":"Anand D, Colpo GD, Zeni G, Zeni CP, Teixeira AL. Attention-deficit\/hyperactivity disorder and inflammation: what does current knowledge tell us? A systematic review. Front Psychiatry. 2017;8:228. https:\/\/doi.org\/10.3389\/fpsyt.2017.00228.","journal-title":"Front Psychiatry"},{"key":"1291_CR121","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-981-19-7376-5_15","volume":"1411","author":"D Vazquez-Gonzalez","year":"2023","unstructured":"Vazquez-Gonzalez D, Carreon-Trujillo S, Alvarez-Arellano L, Abarca-Merlin DM, Dominguez-Lopez P, Salazar-Garcia M, et al. A potential role for neuroinflammation in ADHD. Adv Exp Med Biol. 2023;1411:327\u201356.","journal-title":"Adv Exp Med Biol"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01291-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-026-01291-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01291-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:02:22Z","timestamp":1778101342000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-026-01291-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":121,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1291"],"URL":"https:\/\/doi.org\/10.1007\/s40266-026-01291-z","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dora Wynchank and Sandra Kooij are founders and owners of the\n                      ADHD Powerbank\n                      , an online platform providing short evidence-based educational videos on ADHD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"DW conceived the study, conducted the literature review and drafted the manuscript. SK contributed to the conceptual framework, clinical interpretation and critical revision of the manuscript. Both authors approved the final version for submission.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}